The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats.

Saved in:
Bibliographic Details
Title: The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats.
Authors: Cohen SR; Department of Psychology, Binghamton University, Binghamton, NY, USA., Terry ML; Department of Psychology, Binghamton University, Binghamton, NY, USA., Coyle M; Department of Psychology, Binghamton University, Binghamton, NY, USA., Wheelis E; Department of Psychology, Binghamton University, Binghamton, NY, USA., Centner A; Department of Psychology, Binghamton University, Binghamton, NY, USA., Smith S; Department of Psychology, Binghamton University, Binghamton, NY, USA., Glinski J; Department of Psychology, Binghamton University, Binghamton, NY, USA., Lipari N; Department of Psychology, Binghamton University, Binghamton, NY, USA., Budrow C; Department of Psychology, Binghamton University, Binghamton, NY, USA., Manfredsson FP; Barrow Neurological Institute, Phoenix, AZ, USA., Bishop C; Department of Psychology, Binghamton University, Binghamton, NY, USA. Electronic address: cbishop@binghamton.edu.
Source: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2022 Jun; Vol. 217, pp. 173393. Date of Electronic Publication: 2022 May 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0367050 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5177 (Electronic) Linking ISSN: 00913057 NLM ISO Abbreviation: Pharmacol Biochem Behav Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5177
DOI:10.1016/j.pbb.2022.173393